A meta-analysis of differences in IL-6 and IL-10 between people with and without depression: Exploring the causes of heterogeneity
267
TL;DR: The data highlight that comorbidity and behavioral aspects of depression need to be measured and controlled in future prospective and experimental research testing the inflammatory hypothesis of depression.
read more
Abstract: Epidemiological evidence for the inflammatory hypothesis of depression is largely cross-sectional; people with depression have elevated levels of circulating pro-inflammatory markers compared to people without depression. The limitation of cross sectional research is the potential for extraneous factors to influence observed effects. The purpose of this meta-analysis of cross-sectional studies of interleukin(IL)-6 and IL-10 in people with and without depression is to provide a targeted analysis of potential moderator factors relating to the diagnosis of depression and to physical and psychiatric comorbidity. Electronic searches of Embase and Medline databases were conducted using subject headings "interleukin-6" or "interleukin-10" and those relating to depression. Studies were included if they measured circulating marker levels in serum or plasma in a group of people with and without depressive symptoms (99 studies for IL-6, 19 studies for IL-10). IL-6 was elevated in depressed compared to non-depressed groups (d = 0.46, 99% CI 0.34 to 0.58, I(2) = 85.9%). This effect was larger in subgroups where depressive disorders were diagnosed compared to those with only depressive symptoms via standardized inventory, and subgroups where participants were recruited from inpatient or outpatient settings compared to the general community. The effect was also larger in those who were not selected for a particular comorbidity compared to those selected for cardiovascular disease. IL-10 effect size was not significant (d = -0.31, 99% CI -0.95 to 0.32, I(2) = 94.1%) which was not accounted for in subgroup analyses or meta-regression, indicating there is not a global elevation in cytokines. These data highlight that comorbidity and behavioral aspects of depression need to be measured and controlled in future prospective and experimental research testing the inflammatory hypothesis of depression.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Effort-related motivational effects of the pro-inflammatory cytokine interleukin 1-beta: studies with the concurrent fixed ratio 5/ chow feeding choice task
Eric J. Nunes,Patrick A. Randall,Alexavier Estrada,Brian P. Epling,Evan E. Hart,Christie A. Lee,Younis Baqi,Christa E. Müller,Mercè Correa,Mercè Correa,John D. Salamone +10 more
TL;DR: It is indicated that IL-1β can reduce the tendency to work for food, even at low doses that do not produce a general sickness, malaise, or loss of appetite.
Therapeutic Potential of Vagus Nerve Stimulation for Inflammatory Bowel Diseases.
TL;DR: The vagus nerve is a mixed nerve, comprising 80% afferent fibers and 20% efferent fibers, which allows a bidirectional communication between the central nervous system and the digestive tract as discussed by the authors.
Prophylactic effects of sulforaphane on depression-like behavior and dendritic changes in mice after inflammation.
Ji-chun Zhang,Wei Yao,Chao Dong,Chun Yang,Qian Ren,Min Ma,Mei Han,Jin Wu,Yusuke Ushida,Hiroyuki Suganuma,Kenji Hashimoto +10 more
TL;DR: Dietary intake of SFN-rich broccoli sprout could be prophylactic vegetable to prevent or minimize the relapse by inflammation in the remission state of depressed patients.
100
On the transdiagnostic nature of peripheral biomarkers in major psychiatric disorders: A systematic review.
TL;DR: How current publication practices have led to research fragmentation across diagnoses is discussed, and approaches to face this issue are suggested to reflect transdiagnostic systemic consequences of psychiatric illness.
95
The rapid antidepressant effect of ketamine in rats is associated with down-regulation of pro-inflammatory cytokines in the hippocampus
TL;DR: CUMS-induced depression-like behaviours are associated with a reduction in hippocampal inflammatory mediators, whereas ketamine’s antidepressant effect isassociated with a down-regulation of pro-inflammatory cytokines in the rat hippocampus.
91
References
Measuring inconsistency in meta-analyses
TL;DR: A new quantity is developed, I 2, which the authors believe gives a better measure of the consistency between trials in a meta-analysis, which is susceptible to the number of trials included in the meta- analysis.
Bias in meta-analysis detected by a simple, graphical test
TL;DR: Funnel plots, plots of the trials' effect estimates against sample size, are skewed and asymmetrical in the presence of publication bias and other biases Funnel plot asymmetry, measured by regression analysis, predicts discordance of results when meta-analyses are compared with single large trials.
A rating scale for depression
TL;DR: The present scale has been devised for use only on patients already diagnosed as suffering from affective disorder of depressive type, used for quantifying the results of an interview, and its value depends entirely on the skill of the interviewer in eliciting the necessary information.
32.8K
•Book
Introduction to Meta-Analysis
Michael Borenstein,Larry V. Hedges,Julian P T Higgins,Hannah R. Rothstein +3 more
- 27 Apr 2009
Estimating the mean and variance from the median, range, and the size of a sample.
TL;DR: Two simple formulas are found that estimate the mean using the values of the median, low and high end of the range, and n (the sample size) and these hope to help meta-analysts use clinical trials in their analysis even when not all of the information is available and/or reported.